FMA
MRTX

FNY Managed Accounts’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

FNY Managed Accounts’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,500
Closed -$51.6K – 327
2015
Q3 		$51.6K Buy
+1,500
New +$51.6K 0.14% 125